Mechanisms of beneficial effects of metformin on fatty acid-treated human islets

Journal of Molecular Endocrinology
Jing CenPeter Bergsten

Abstract

Elevated levels of palmitate accentuate glucose-stimulated insulin secretion (GSIS) after short-term and cause beta-cell dysfunction after prolonged exposure. We investigated whether metformin, the first-line oral drug for treatment of T2DM, has beneficial effects on FFA-treated human islets and the potential mechanisms behind the effects. Insulin secretion, oxygen consumption rate (OCR), AMPK activation, ER stress and apoptosis were examined in isolated human islets after exposure to elevated levels of palmitate in the absence or presence of metformin. Palmitate exposure doubled GSIS after 2 days but halved after 7 days compared with control. Inclusion of metformin during palmitate exposure normalized insulin secretion both after 2 and 7 days. After 2-day exposure to palmitate, OCR and the marker of the adaptive arm of ER stress response (sorcin) were significantly raised whereas AMPK phosphorylation, markers of pro-apoptotic arm of ER stress response (p-EIF2α and CHOP) and apoptosis (cleaved caspase 3) were not affected. Presence of metformin during 2-day palmitate exposure normalized OCR and sorcin levels. After 7-day exposure to palmitate, OCR and sorcin were not significantly different from control level, p-AMPK was reduce...Continue Reading

References

Nov 1, 1985·The Journal of Clinical Endocrinology and Metabolism·E FrazeG M Reaven
Oct 17, 2001·The Journal of Clinical Investigation·G ZhouD E Moller
Nov 26, 2002·Biochimica Et Biophysica Acta·Masatoshi MakiHideki Shibata
May 29, 2003·The Journal of Biological Chemistry·Cynthia L KelpeVincent Poitout
Nov 9, 2004·The Journal of Clinical Endocrinology and Metabolism·Piero MarchettiStefano Del Prato
Nov 29, 2005·Best Practice & Research. Clinical Endocrinology & Metabolism·A Golay, J Ybarra
Nov 23, 2006·Biochemical and Biophysical Research Communications·Xiao WangMin Luo
Jun 19, 2008·Journal of Cell Science·Daniel A CunhaMiriam Cnop
Jul 23, 2008·The Journal of Endocrinology·Ernest SargsyanPeter Bergsten
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Nov 29, 2011·Clinical Science·Benoit ViolletFabrizio Andreelli
Sep 17, 2013·Endocrinology·Hjalti KristinssonErnest Sargsyan
Mar 20, 2014·International Journal of Biological Sciences·Yingling JiangJingjing Zhang
Jan 30, 2016·Diabetes·Alice MarmugiIsabelle Leclerc
Jul 30, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Lars C GormsenNiels Jessen

❮ Previous
Next ❯

Citations

Sep 23, 2018·International Journal of Molecular Sciences·Joseph ZhouLixin Li
May 18, 2019·Journal of Endocrinological Investigation·S E MeshkaniH Hosseinzadeh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.